Antioxidant/anticancer agent 1 (compound 5) is a pyrimidine-derivatized Schiff base based on pyrimidine hydroxy-1-naphthaldehyde and has antibacterial , antioxidant, antifungal , and anticancer properties. Antioxidant/anticancer agent 1.
Specifiche
Condizioni di conservazione di stoccaggio
Store at -20°C
Spedito in
Ice chest + Ice pads
Questo prodotto richiede spedizione a catena fredda. I servizi di terra e altri servizi economici non sono disponibili.
Tipo di azione
INHIBITOR
Nomi e identificatori
Peso molecolare
293.32
Dati avanzati
Certificati (CoA, COO, BSE/TSE e tabella di analisi)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Calcolatori di soluzioni
Molarity Calculator
Determine the necessary mass, volume, or concentration for preparing a solution.
Dilution Calculator
Determine the dilution needed to prepare a stock solution.
Reconstitution Calculator
Recensioni
Recensioni dei clienti
Application Protocols
No vendor-tested biological application data are provided for this specific item. The following generic protocols are commonly used to evaluate antioxidant and antiproliferative activity (general guidance; not item-specific):
DPPH/ABTS radical scavenging (spectrophotometric)
Prepare 10–50 mM DMSO stock; serially dilute to 0.1–200 µM final.
Mix test solutions with DPPH (∼100 µM in MeOH) or ABTS•+ working solution.
Incubate in the dark (15–30 min), then read absorbance (DPPH: 517 nm; ABTS: 734 nm).
Calculate % inhibition vs vehicle; include Trolox standard curve to express Trolox equivalents.
Cellular ROS assay (DCFH-DA)
Load cells with DCFH-DA (10 µM, 30 min), wash, then treat with compound ± ROS inducer (e.g., t-BHP) at 0.1–50 µM.
Measure fluorescence (Ex/Em 485/535 nm) over 0–120 min. Control for autofluorescence and DMSO content.
Cell viability (MTT/Resazurin/ATP-based)
Seed cells (e.g., 5–10×10^3 cells/well, 96-well). Treat with 0.03–100 µM compound for 24–72 h.
Read assay per kit instructions; compute IC50/EC50 via nonlinear regression.
Apoptosis/Cell cycle (Annexin V/PI; PI or DAPI DNA content)
Treat cells with graded concentrations; harvest at 24–48 h.
Analyze by flow cytometry; include positive controls (e.g., staurosporine for apoptosis).
Always incorporate vehicle controls, verify solubility post-dilution, and confirm hits with orthogonal assays to rule out assay interference.
Biological Roles
Item-specific biological mechanism/targets are not provided. The following summarizes common biological roles explored for antioxidant and anticancer chemotypes in research (general background; not item-specific):
Oxidative stress modulation: Compounds may act as radical scavengers, metal chelators, redox enzyme modulators, or inducers of endogenous defense pathways (e.g., Nrf2/Keap1–ARE axis). Researchers often quantify changes in GSH/GSSG, NADPH/NADP+, and expression of HO-1, NQO1, GCLC.
Mitochondrial function: Redox-active molecules can affect mitochondrial membrane potential, respiratory chain function, and ROS production. Readouts include JC-1/TMRE, Seahorse respirometry, and mitochondrial ROS probes (MitoSOX).
Cell proliferation and death pathways: Antiproliferative chemotypes are evaluated for effects on the cell cycle (CDKs, cyclins), apoptosis (caspases, Bcl-2 family), and sometimes non-apoptotic death pathways (autophagy, ferroptosis). These are investigated via Western blotting, flow cytometry, and imaging assays.
DNA damage response: Oxidative or targeted mechanisms may engage DDR pathways (ATM/ATR, p53). Markers such as γH2AX foci and comet assays assess DNA integrity.
Redox–signaling crosstalk: NRF2, NF-κB, HIF-1α, and MAPK pathways frequently intersect with oxidative stress and survival decisions; pathway reporter assays can clarify upstream effects.
Caution: None of the above mechanisms are assigned to this specific item. All experimental conclusions should be based on data generated with appropriate controls and orthogonal confirmation.
Buffer Applications
This product is a small-molecule screening compound and is not itself a buffering agent. However, buffer choice critically affects solubility, stability, and assay performance for antioxidant/oncology research (general guidance; not item-specific):
Common buffers and uses:
PBS or HBSS for cell-based assays; maintain physiological pH 7.2–7.4.
HEPES (10–25 mM) for CO2-independent pH control in imaging/biochemical assays.
Tris or MOPS for enzyme assays where phosphate may interfere with metal-dependent enzymes or redox probes.
Co-solvent strategies: Add 0.1–0.5% DMSO to reduce precipitation when diluting DMSO stocks into aqueous buffers. Verify assay tolerance to DMSO.
Additives to aid solubility: 2–10 mM HP-β-cyclodextrin; 0.01–0.05% nonionic surfactant (e.g., Tween 20/80) if compatible with readouts.
Redox assay considerations:
Use metal chelators (e.g., 100–500 µM DTPA) in buffer to suppress Fenton chemistry during ROS measurements, if appropriate.
Prepare fresh buffers and degas/argon-sparge when assessing oxygen-sensitive endpoints.
Adsorption/light:
Use low-binding plasticware or glass for hydrophobic compounds; precondition plastics with buffer containing 0.1% BSA if nonspecific binding is problematic (verify no assay interference).
Protect from light for photolabile redox probes and potentially light-sensitive test articles.
Always validate buffer composition and vehicle controls alongside assay conditions.
Green Alternatives
While this item is a screening compound rather than a solvent or reagent, greener choices can be made in its handling and assay preparation (general guidance; not item-specific):
Stock solutions: Prefer DMSO over halogenated solvents. If DMSO is unsuitable, assess bio-based alternatives like Cyrene (dihydrolevoglucosenone) or 2-MeTHF for synthetic steps or intermediate handling, recognizing compatibility constraints with biological assays.
Aqueous delivery: Use minimal co-solvent percentages and consider cyclodextrin inclusion (HP-β-CD) or serum proteins in media to aid solubilization, reducing reliance on higher-toxicity solvents (DMF/NMP).
Extraction/cleanup: For workups during analytical method development, replace dichloromethane/chloroform with ethyl acetate or MTBE where feasible; use water/MeOH gradients instead of acetonitrile-heavy methods if resolution allows.
Comparison (general, trade-offs):
DMSO vs DMF/NMP: DMSO is generally lower hazard and more assay-compatible; DMF/NMP offer higher solvating power but have greater health and regulatory concerns.
Ethyl acetate vs DCM: EtOAc is less persistent/toxic; may require larger volumes or salting-out to match extraction efficiency.
Cyrene vs DMF: Cyrene is greener but more viscous and can impact chromatographic/assay baselines—pilot testing required.
Operational tips:
Scale down assay volumes and adopt miniaturized formats (96/384-well) to reduce solvent usage and waste.
Segregate and label halogenated vs non-halogenated waste to enable more sustainable disposal routes.
Pharmaceutical Uses
No pharmacopeial status, dosage form, or clinical use is provided for this item. It is supplied strictly for research use only.
General, non-clinical formulation considerations for early discovery compounds (not item-specific):
Preformulation profiling: Determine solubility (aqueous and biorelevant media), pKa, logD, and chemical stability (pH, oxidative, photolytic). These data inform selection of in vitro vehicle systems and preliminary in vivo enabling formulations, if conducted under appropriate institutional oversight.
Vehicles for in vitro work: DMSO stock solutions diluted into media with final DMSO ≤0.1–0.5%. For less soluble compounds, co-solvent blends (e.g., PEG 400, ethanol, saline) may be used at low percentages in strictly research contexts.
Salt/cocrystal options: If the compound is ionizable, exploratory salt screening can enhance solubility and stability. Not specified for this item; consult CoA for salt form.
Solid-state stability: Assess hygroscopicity and potential polymorphism by DSC/TGA/XRPD to support reproducible handling.
Compliance note: Do not use in humans or for diagnostic purposes. Any in vivo research must follow institutional, ethical, and regulatory requirements; this listing makes no claims regarding safety, efficacy, or suitability for therapeutic use.
Physical Properties
Item-specific properties (from Product Data):
Appearance: Not specified for this item; refer to CoA/Spec Sheet.
Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.
Literature/computed values: Not available without structure; no literature properties can be cited for CAS 1449470-38-5 in this listing.
General chemistry guidance for handling unknown small molecules (not item-specific):
Melting/boiling point: For solid screening compounds, expect a melting point within 60–250 °C (broad literature range). Liquids/oils may occur for lipophilic scaffolds. Confirm experimentally by DSC/melting point if formulation stability depends on phase.
Solubility: Begin with dry DMSO (analytical grade) to prepare stock solutions (e.g., 10–50 mM). If insoluble, consider DMF or NMP, or co-solvent systems (DMSO:water or DMSO:PBS) and solubilization aids (HP-β-CD, small % of ethanol or PEG 400).
LogP/ionization: Unknown here. If required for assay design, measure by shake-flask or estimate via in silico tools; confirm pKa by potentiometric titration or UV-metric methods.
Optical properties: If the compound is colored/aromatic, UV absorbance may interfere with some readouts. Record UV–Vis spectrum (200–800 nm) in assay buffer with co-solvent to assess interference risk.
Hygroscopicity/polymorphism: Unknown. Minimize ambient exposure and record any visual changes upon opening.
Quality and Grades
Item-specific (from Product Data):
Grade/purity: Not specified for this item; refer to CoA/Spec Sheet.
Interpretation and expectations (general guidance for library compounds; not item-specific):
Typical library compound QC includes purity by HPLC/UPLC (often ≥95% area by a specified method), identity confirmation by LC–MS and/or 1H NMR, and documentation of salt form/solvate state. Verify the actual acceptance criteria on the CoA for this SKU/lot.
If a stabilizer or counter-ion is present (e.g., TFA salt, HCl salt), it will influence solubility, hygroscopicity, and pH in aqueous media. No stabilizer is disclosed here; confirm on CoA.
UV cutoff, water content, residual solvents, and metal content are sometimes reported for screening compounds but are not specified for this item; refer to CoA/Spec Sheet.
For sensitive assays (e.g., redox or ROS measurements), low-peroxide, low-impurity solvents and containers can be critical. Validate background signal with vehicle-only controls.
Best practices:
Record lot/batch number with each experiment; attach CoA and any vendor spectra in your ELN.
If in-house QC is needed, run orthogonal purity/identity checks (e.g., qNMR, HRMS, and orthogonal chromatographic methods at multiple wavelengths) before critical studies.
Reaction and Applications
This product is supplied as a screening small molecule labeled “Antioxidant/anticancer agent 1.” It is not primarily intended as a synthetic reagent. No reaction chemistry, catalysts, or named-reaction roles are specified for this item.
General research applications for antioxidant/anticancer chemotypes (not item-specific):
Antioxidant assays: DPPH, ABTS, FRAP, ORAC, and cellular ROS assays (e.g., DCFH-DA) to profile radical scavenging or redox-modulating capacity in vitro. Include well-characterized positive controls (Trolox for antioxidant assays) and vehicle controls.
Cell-based oncology models: Proliferation/viability (MTT, resazurin/AlamarBlue, CellTiter-Glo), clonogenic survival, apoptosis markers (caspase-3/7 activity, Annexin V/PI), and cell cycle analysis by flow cytometry. Titrate compound to identify IC50/EC50 as appropriate; avoid exceeding tolerated vehicle levels.
Mechanistic exploration: If the scaffold is suspected to impact redox pathways, investigators often test Nrf2/Keap1 signaling (ARE-luciferase reporters), glutathione status (GSH/GSSG), mitochondrial potential (JC-1/TMRE), and oxidative DNA damage (8-oxo-dG). These are general strategies; no mechanism is claimed for this item.
Chemical biology: Use concentration–response and time-course designs to distinguish immediate redox modulation from downstream cytostatic effects.
Notes:
Validate solubility/absence of aggregation (e.g., DLS or detergent controls) before interpreting biochemical inhibition data.
For follow-up, orthogonal assays and counterscreens help exclude assay interference or redox cycling artifacts.
Reaction Conditions
Not applicable in the traditional synthetic sense: this item is a screening compound, not supplied for use as a reagent/catalyst.
General experimental conditions relevant to biological evaluation (not item-specific):
Stock preparation: Dissolve in anhydrous DMSO at 10–50 mM; verify complete dissolution by visual inspection and, if necessary, LC monitoring. Filter (0.2 µm PTFE) if particulates persist.
Assay incubation: Typical small-molecule assays use 0.1–50 µM final concentrations with exposure times from 30 min (biochemical) to 24–72 h (cell-based). Optimize vehicle percentage (commonly ≤0.1–0.5% DMSO).
Temperature/light: Perform cell assays at 37 °C, 5% CO2 as applicable; protect light-sensitive endpoints and potential chromophores by wrapping plates in foil.
Controls: Include vehicle controls, positive controls (e.g., Trolox for antioxidant assays), and counterscreens to detect redox cycling or general cytotoxicity.
Stability checks: After dilution into media/buffer, monitor for precipitation/turbidity over the assay window. Consider time-course LC–MS to identify degradation.
Note: All conditions above are general literature practices and must be tailored empirically. No item-specific conditions are provided by the Product Data.
Safety and Handling
Authoritative safety data are provided in the SDS; always consult the SDS for this specific item/lot.
Item-specific hazard information from Product Data:
Signal word: Not specified for this item; refer to SDS.
H-statements: Not specified for this item; refer to SDS.
GHS classification/pictograms: Not specified for this item; refer to SDS.
General laboratory precautions for small-molecule screening compounds (not item-specific):
PPE: Laboratory coat, safety glasses, and appropriate chemically resistant gloves (e.g., disposable nitrile). Avoid skin contact, ingestion, and inhalation of dusts/aerosols.
Engineering controls: Work in a chemical fume hood when weighing, dissolving, or aliquoting powders; minimize aerosol generation.
Handling: Many bioactive small molecules are readily absorbed through skin, especially in DMSO. Prevent dermal exposure and promptly clean spills. Use dedicated, labeled containers for stock solutions.
Incompatibilities: Unknown for this specific compound. As a precaution, segregate from strong oxidizers/reductants and acids/bases until compatibility is confirmed.
First aid (overview; defer to SDS): Inhalation—move to fresh air; Skin—wash with soap/water; Eyes—rinse cautiously for minutes; Ingestion—rinse mouth and seek medical attention. Provide SDS to responders.
Waste: Collect solutions/solids as organic chemical waste per institutional and local regulations.
Transport/storage risks: Ship and store cold as provided; avoid repeated freeze–thaw to limit degradation. If light-sensitive chromophores are suspected, protect from light.
Solvent Selection
Item-specific solubility data are not provided for this compound. The following are general, practitioner-focused strategies for small-molecule solubilization (not item-specific):
Primary stock solvent: Use anhydrous DMSO to prepare 10–50 mM stocks. Confirm clarity visually; if hazy, sonicate gently or warm to 30–40 °C briefly, then re-cool before use.
Secondary options: DMF or NMP can dissolve highly lipophilic/rigid scaffolds; use in low final assay percentages (<0.5–1% v/v) due to cytotoxicity.
Aqueous formulation:
For neutral/lipophilic compounds: Employ co-solvent systems (e.g., DMSO 0.1–1% v/v) or solubilizers (2–10 mM HP-β-cyclodextrin) to prevent precipitation upon dilution into buffers.
For ionizable compounds: Adjust pH within 0.5–1 unit of the pKa (if known/estimated) to maximize solubility, ensuring assay compatibility. Perform micro-pH scouting if feasible.
Surfactants: Nonionic surfactants (e.g., 0.01–0.05% Tween 80 or Pluronic F-127) can improve dispersion in biochemical assays; verify no interference with readouts.
Light/adsorption considerations: Some aromatic compounds adsorb to plastics; use low-binding polypropylene or glass vials. Protect from light if chromophores suspected.
Quick comparison (general):
DMSO: Highest solvating power, broad compatibility, but enhances dermal absorption; keep final assay ≤0.1–0.5% when possible.
Ethanol: Good for moderately polar compounds; higher assay tolerability than DMF/NMP.
PEG 400/propylene glycol: Useful for in vitro biochemical setups; viscosity may affect pipetting—pre-warm for accuracy.
Storage and Reconstitution
Item-specific (from Product Data):
Storage: Store at -20°C.
Shipped: On ice (ice chest + ice pads).
General best practices for small-molecule screening compounds (not item-specific):
Upon receipt: Allow to equilibrate to room temperature in sealed packaging to prevent condensation. Inspect for any visible changes.
Reconstitution: Use anhydrous DMSO to prepare concentrated stocks (e.g., 10–50 mM). If solubility is limited, consider DMF or co-solvent systems compatible with downstream assays.
Aliquoting: Dispense into single-use, low-dead-volume aliquots (amber vials or low-bind tubes) to avoid repeated freeze–thaw. Typical aliquot size: 10–50 µL.
Storage of solutions: Store DMSO stocks at -20°C or below, desiccated and protected from light. Record preparation date; re-test after several months for potency/identity by LC–MS.
Freeze–thaw: Avoid; if unavoidable, limit to ≤2 cycles. Thaw on ice or at room temperature; mix gently and inspect for precipitation.
Photostability: If chromophoric or suspected light-sensitive, wrap containers in aluminum foil or use amberware during handling and storage.
Aqueous dilutions: Prepare freshly before use. Discard unused working solutions after the experiment unless stability is demonstrated.
Note: Appearance, exact solubility, and stabilizers are not specified for this item; refer to the CoA/Spec Sheet and SDS for definitive instructions.
Structure and Identity
Concise overview for a small-molecule screening candidate supplied as part of a compound library.
Item-specific (from Product Data):
Product Name: Antioxidant/anticancer agent 1
CAS: 1449470-38-5
SKU: A1420566
Category: Small molecules and compound libraries (研究/筛选用途)
Storage: Store at -20°C
Shipping: Ice chest + ice pads
Research Use: For research use only
Item-specific identifiers not provided: Molecular formula, molecular weight, SMILES, InChIKey, IUPAC name, structural class. Not specified for this item; refer to CoA/Spec Sheet.
Structural features (descriptive): Not disclosed in the provided data; consult the CoA/SDS for structural information if needed for registration or method development.
2D structure (verbal): Not available in the provided data. If required, retrieve from the CoA, vendor spectral pack, or by querying the CAS registry listing for 1449470-38-5 (ensure cross-verification before use).
Notes for registries and ELNs (general guidance):
When registering screening compounds with limited metadata, include vendor SKU, CAS, lot/batch, and any available spectral/QC attachments to maintain traceability.
If structure is proprietary or blinded for screening, track it as a coded entity with controlled access and link to decoding key post-screen.
Synthetic Utility
This product is offered as a finished small-molecule screening entity rather than a synthetic building block or reagent. No reactive functional groups or derivatization handles are disclosed in the provided data.
General notes (not item-specific):
If structural information becomes available and the scaffold is of interest for SAR, consider purchasing additional analogs or, where permitted, conducting parallel synthesis to explore substituent effects. Maintain rigorous analytical identity/purity checks for all analogs used in biological testing.
For bioconjugation or probe development, structural motifs such as anilines, phenols, carboxylic acids, or halides can be leveraged for linker installation; however, the presence/absence of such groups is unknown for this item.
Bottom line: Treat this compound as a test article for screening rather than as a reagent for transformations. Consult the CoA or vendor if a functionalized derivative is required.
Target Specificity
Item-specific target information is not provided in the Product Data. No protein, pathway, or cellular target selectivity can be claimed for this compound.
General guidance (not item-specific):
If target engagement is hypothesized, use orthogonal assays such as thermal shift (CETSA/DSF), cellular target engagement reporters, or biochemical enzyme kinetics to confirm specificity.
Counterscreens against related isoforms or off-target panels (e.g., kinases, receptors, redox enzymes) are recommended to assess selectivity.
For antioxidant mechanisms, distinguish direct radical scavenging from pathway modulation (e.g., Nrf2 activation) using appropriate reporter assays and redox probes.
Conclusion: Target specificity is undetermined for this item; refer to your experimental data and any CoA/technical note updates.
Domande frequenti
How should this product be stored?
Store at ?20 °C. Freezer storage is required to maintain the specified shelf life.
How is this product shipped?
This product ships in an insulated container with ice pads. Unpack on arrival and transfer it to the storage condition stated above.
What are the CAS number, molecular formula and molecular weight?
The CAS Number is 1449470-38-5, the molecular formula is C17H15N3O2, and the molecular weight is 293.32 g/mol.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.
Utilizziamo i cookie per garantire il corretto funzionamento del sito web e, ove consentito, per migliorare la tua esperienza. Puoi gestire le tue preferenze in qualsiasi momento nelle Impostazioni. Per saperne di più, consulta la nostra Cookie Policy.
Desidera che le inviamo un messaggio quando avremo sconti disponibili?
Ricordamelo più tardi
Grazie! Controlli la sua casella di posta per confermare.
Products are supplied to verified businesses, institutions, and qualified professionals for research and development use only. Not for use in humans, animals, diagnosis, or therapy.